The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study

Overview of attention for article published in Aging, November 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 5 news outlets
blogs: 2 blogs
twitter: 18 X users
facebook: 1 Facebook page

reddit: 1 Redditor
video: 1 YouTube creator
podcasts: 1 podcast

Readers on

mendeley: 14 Mendeley

So far, Altmetric has seen 3 posts from 2 blogs.

Metformin use history and genome-wide DNA methylation profile: potential molecular mechanism for aging and longevity

aging-us.net, 15 Feb 2023

The post <a href="https://www.aging-us.com/article/204498/text">Metformin use history and genome-wide DNA methylation profile…

Aging | The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study

aging-us.net, 07 Dec 2022

“In this report, we showed the potential benefit of metformin in decreasing the risk of delirium and mortality in DM [diabetes…

Aging | The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study

Impact Journals - Blogs, 07 Dec 2022

“In this report, we showed the potential benefit of metformin in decreasing the risk of delirium and mortality in DM [diabetes…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.